Abstract
Endothelial and vascular damage are main leading disability in systemic sclerosis (SSc). Raynaud’s phenomenon is the early symptom that presents vascular damage. Nailfold capillaroscopy (NFC) is an easily accessible diagnostic tool in secondary Raynaud’s phenomenon. Considering the endothelial damage, clinical manifestations, and plasma cytokines was compared with traditionally used NFC parameter for, which to observe the number of capillaries, deletions in 3 mm, apical limb width and the capillary width itself. We hypothesize that a computer-based NFC system can generate a new powerful parameter which predicts the capillary dimension. We investigated the relationship among the plasma endothelin-1 (ET-1), clinical manifestations and quantitative analysis of computerized NFC, and to assess the optimal method in SSc. The level of ET-1 in 60 SSc patients, 30 healthy, and 23 disease controls were measured by enzyme-linked immunosorbent assay (ELISA) kit. We present a significant difference in all parameters of NFC between SSc patients and control groups. ET-1 level was increased in patients with SSc. In SSc group, capillary dimension and loss of capillaries were strongly associated with digital ulceration (p < 0.01) and pulmonary hypertension (p < 0.05). Capillary dimension and ET-1 level was in correlation with skin-hardening grade, and was higher in SSc patients with pulmonary hypertension or digital ulcer. Capillary dimension showed strong correlation with the endothelin-1 in SSc, healthy and disease control groups. (Rs = 0.31/p < 0.05, Rs = 0.82/p < 0.001, Rs = 0.83/p < 0.001). The results suggest that computer-based microscopic analysis of NFC is a useful method that potentially provides information on organ involvement and plasma ET-1. Capillary dimension maybe a powerful parameter possibly applicable in outpatient clinic for assessing SSc patients.
Similar content being viewed by others
References
LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205
Wollheim FA (2005) Classification of systemic sclerosis. Visions and reality. Rheumatology (Oxford) 44:1212–1216
Bukhari M, Hollis S, Moore T et al (2000) Quantitation of microcirculatory abnormalities in patients with primary Raynaud’s phenomenon and systemic sclerosis by video capillaroscopy. Rheumatology (Oxford) 39:506–512
Schur PH, Scmerlig RH (2003) Laboratory tests in rheumatic disorders. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology, 3rd edn. Mosby Press, New York, pp 199–213
Cutolo M, Sulli A, Pizzorni C et al (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160
Markus B, Ricardo MX, Karina GC et al (2004) Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis. J Rheumatol 31:286–294
Kuryliszyn-Moskal A, Klimiuk PA, Sierakowski S (2005) Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement. Clin Rheumatol 24:111–116
Choi JJ, Min DJ, Cho ML et al (2003) Elevated vascular endothelial growth factor in systemic sclerosis. J Rheumatol 30:1529–1533
Kahaleh B, Meyer O, Scorza R (2003) Assessment of vascular involvement. Clin Exp Rheumatol 21:S9–S14
Zamora MR, O’Brien RF, Rutherford RB et al (1990) Serum endothelin-1 concentrations and cold provocation in primary Raynaud’s phenomenon. Lancet 336:1144–1147
Rubens C, Ewert R, Halank M et al (2001) Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest 120:1562–1569
Czirjak L, Kiss CG, Lovei C et al (2005) Survey of Raynaud’s phenomenon and systemic sclerosis based on a representative study of 10, 000 south-Transdanubian Hungarian inhabitants. Clin Exp Rheumatol 23:801–808
Do JH, Kim HY (2004) Increased plasma endothelin-1 and abnormal nailfold capillaroscopic findings in patients with connective tissue diseases. The Korean J of Med 66:275–283
Halfoun VL, Pires ML, Fernandes TJ et al (2003) Videocapillaroscopy and diabetes mellitus: area of transverse segment in nailfold capillar loops reflects vascular reactivity. Diabetes Res Clin Pract 61:155–160
Wildt M, Hesselstrand R, Scheja A et al (1999) Capillary density in patients with systemic sclerosis, as determined by microscopy counts and compared with computer-based analysis. Clin Exp Rheumatol 17:219–222
American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590
Maricq HR, LeRoy EC, D’Angelo WA et al (1980) Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 23:183–189
Schmidt KU, Mensing H (1988) Are nailfold capillary changes indicators of organ involvement in progressive systemic sclerosis? Dermatologica 176:18–21
Carpentier PH, Maricq HR (1990) Microvasculature in systemic sclerosis. Rheum Dis Clin North Am 16:75–91
Ohtsuka T, Hasegawa A, Nakano A et al (1997) Nailfold capillary abnormality and pulmonary hypertension in systemic sclerosis. Int J Dermatol 36:116–122
Pucinelli ML, Atra E, Sato EI et al (1995) Nailfold capillaroscopy in systemic sclerosis: correlations with involvement of lung and esophagus. Rev Bras Rheumatol 35:136–142
Groen H, Wichers G, ter Borg EJ et al (1990) Pulmonary diffusing capacity disturbances are related to nailfold capillary changes in patients with Raynaud’s phenomenon with and without an underlying connective tissue disease. Am J Med 89:34–41
Anderson ME, Allen PD, Moore T et al (2005) Computerized nailfold video capillaroscopy-a new tool for assessment of Raynaud’s phenomenon. J Rheumatol 32:841–848
Levin ER (1995) Endothelins. N Eng J Med 333:356–363
Faller DV (1999) Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol 26:74–84
Brain SD, Tippins JR, Williams TJ (1988) Endothelin induces potent microvascular constriction. Br J Pharmacol 95:1005–1007
Morelli S, Ferri C, di Francesco L et al (1995) Plasma endothelin-1 levels in patients with systemic sclerosis: influence of pulmonary or systemic arterial hypertension. Ann Rheum Dis 54:730–734
Scala E, Pallotta S, Frezzolini A et al (2004) Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol 138:540–546
Kaplanski G, Marin V, Montero-Julian F et al (2003) IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol 24:25–29
Acknowledgement
This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education, Science and Technology(2009-0062891).
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, HS., Park, MK., Kim, HY. et al. Capillary dimension measured by computer-based digitalized image correlated with plasma endothelin-1 levels in patients with systemic sclerosis. Clin Rheumatol 29, 247–254 (2010). https://doi.org/10.1007/s10067-009-1288-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-009-1288-7